Abstract
Importance The American Heart Association introduced Life’s Essential 8 (LE8) as a checklist of healthy lifestyle factors to help older individuals maintain and improve cardiovascular health and live longer. How LE8 can foster healthy brain aging and interact with genetic risk factors to render the aging brain less vulnerable to dementia is not well understood.
Objective To investigate the impact of LE8 on the white matter brain aging and the moderating effects of the APOE4 allele.
Design, Setting, and Participants This cross-sectional study uses genetic, imaging, and other health-related data collected in the UK Biobank cohort. Participants included non-pregnant whites with LE8 variables, diffusion tensor imaging data, and genetic data on APOE4 available, and excluded the extreme white matter hyperintensities. The baseline assessment was performed from 2006 to 2010. The diffusion tensor imaging data were collected since 2014.
Exposures LE8 variables, encompassing diet, physical activity, smoking, sleep, body mass index, lipids, hemoglobin, and blood pressure.
Main Outcomes and Measures The white matter brain age was predicted from regional fractional anisotropy measures derived from diffusion tensor imaging data using the random forest regression method. The outcome white matter brain age gap was calculated by subtracting individuals’ chronological age from their predicted brain age.
Results The analysis included 9,430 women and 9,387 men (mean age 55.45 [SD: 7.46] years). Higher LE8 scores were associated with lower white matter brain age gap, indicating delayed brain aging. The findings are consistent for each of the individual LE8 variables. The effect was stronger among non-APOE4 carriers (124 days younger per 10-point increase, 95% CI, 102 to 146 days; P<0.001) than APOE4 carriers (84 days younger per 10-point increase, 95% CI, 47 to 120 days; P<0.001). Notably, early middle-aged women with APOE4 showed significant interactions between LE8 scores and brain aging (P interaction = 0.048), not observed in men.
Conclusions and Relevance Adherence to LE8 is associated with delayed brain aging, moderated by genetic factors such as APOE4. These findings highlight the potential of behavioral and lifestyle interventions in reducing dementia risk, emphasizing tailored prevention plans for those with different genetic predispositions to dementia and sex.
Competing Interest Statement
In the last 36 months, RGM has received support from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH), National Institute on Aging (NIA) of the NIH, Patient Centered Outcomes Research Institute (PCORI), National Center for Advancing Translational Sciences (NCATS), and the American Diabetes Association. She serves as a consultant to EmmiEducate (Wolters Kluwer) and the Yale-New Haven Health System's Center for Outcomes Research and Evaluation, and has received speaking honoraria and travel support from the American Diabetes Association.
Funding Statement
Research reported in this publication was supported by the National Institute on Drug Abuse (NIDA) of National Institute of Health under the award number 1DP1DA048968-01 to SC and TM, by the National Institute on Drug Abuse (NIDA) under the award number 1K01DA059603-01A1 to TM, by the University of Maryland MPower Brain Health and Human Performance seed grant to TM and PK, by the Grand Challenge Grant to TM, and EPIB Department Pilot Award to TM, TN and YL. RGM, SC, CC, JC, are TN are investigators at the University of Maryland-Institute for Health Computing, which is supported by funding from Montgomery County, Maryland and The University of Maryland Strategic Partnership: MPowering the State, a formal collaboration between the University of Maryland, College Park and the University of Maryland, Baltimore.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The raw genetic and phenotypic data used for this study can be found in the UK Biobank (http://www.ukbiobank.ac.uk/)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
6
Blogs/Media
Author Videos